Best Treatment for Herpes Simplex Virus (HSV)
The Centers for Disease Control and Prevention (CDC) recommends oral acyclovir, valacyclovir, or famciclovir as first-line treatments for HSV infections, with specific dosing regimens based on whether it's a first episode, recurrent episode, or suppressive therapy. 1
First-Line Treatment Options
First Clinical Episode
- Acyclovir: 200 mg orally 5 times daily for 7-10 days 1
- Alternative regimens:
Recurrent Episodes
- Acyclovir: 400 mg orally 3 times daily for 5 days
- Alternative regimens:
- Acyclovir 800 mg orally 2 times daily for 5 days
- Acyclovir 800 mg orally 3 times daily for 2 days (shorter course option) 3
Suppressive Therapy (for frequent recurrences ≥6 per year)
- Acyclovir: 400 mg orally 2 times daily
- Alternative: Acyclovir 200 mg orally 3-5 times daily 1
- Suppressive therapy reduces recurrence frequency by at least 75% 1
Treatment Duration
- First episodes: 7-10 days
- Recurrent episodes: 5 days
- Continue treatment until all lesions have completely healed 1
Special Populations
Immunocompromised Patients
- Higher risk of severe disease and antiviral resistance
- May require longer treatment duration and closer monitoring 1
- For acyclovir-resistant HSV:
Children (<45 kg)
- Acyclovir 20 mg/kg body weight (maximum 800 mg/dose) orally 4 times daily for 7-10 days 1
HIV-Infected Patients
- Higher oral doses may be required, especially with CD4+ counts <200 cells/μL 1
Dose Adjustment for Renal Impairment
- Dosage adjustment required based on creatinine clearance:
| Creatinine Clearance (mL/min) | Acyclovir 200 mg | Acyclovir 400 mg | Acyclovir 800 mg |
|---|---|---|---|
| >25 | Every 4h, 5x/day | Every 12h | Every 4h, 5x/day |
| 10-25 | Every 4h, 5x/day | Every 12h | Every 8h |
| 0-10 | Every 12h | Every 12h | Every 12h |
Pain Management
- Mild pain: Acetaminophen or NSAIDs
- Moderate pain: Consider adding gabapentin or pregabalin
- Severe pain: Short-term opioid analgesics may be required
- Topical options: Lidocaine patches or capsaicin cream 1
Important Considerations
Efficacy Factors
- Early treatment initiation improves outcomes
- Valacyclovir has better bioavailability than acyclovir and allows for less frequent dosing (twice daily vs. five times daily) while maintaining equivalent efficacy 2
- Topical acyclovir is substantially less effective than oral therapy and is not recommended for most indications 1
Prevention Strategies
- Abstain from sexual activity while lesions are present
- Use condoms during all sexual exposures
- Inform sexual partners about HSV status 1
Common Pitfalls
- Delayed treatment - decreases efficacy
- Underdosing - can lead to treatment failure
- Premature discontinuation - can lead to recurrence
- Inadequate pain management - decreases quality of life
- Failure to recognize resistance - particularly in immunocompromised patients 1
Treatment Algorithm
- Assess patient status: First episode vs. recurrent vs. suppressive therapy need
- Evaluate immune status: Immunocompetent vs. immunocompromised
- Select appropriate regimen based on above factors
- Adjust dose for renal impairment if needed
- Monitor response and continue until complete healing
- Consider suppressive therapy for patients with frequent recurrences